Nyxoah SA (NYXH) vs Profound Medical (PROF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Profound Medical (PROF) has outperformed Nyxoah SA (NYXH) over the past year, gaining 2.5% versus a loss of 77.9%. Over five years, PROF leads with a -54.0% price change compared with -94.7% for NYXH. Profound Medical is the larger company by market cap ($252.5 million vs $137.5 million), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NYXH | PROF |
|---|---|---|
| Share price | $1.35 | $6.91 |
| Market cap | $137.48M | $252.49M |
| 1-day change | -4.93% | +21.65% |
| YTD return | -70.65% | -12.20% |
| 1-year return | -77.87% | +2.52% |
| 5-year return | -94.71% | -53.96% |
| EPS (TTM) | $-2.56 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.88 | $8.95 |
| 52-week low | $1.26 | $4.80 |
| Distance from 52-week high | -80.36% | -22.79% |
| Analyst consensus | none | none |
| Avg. price target upside | +211.11% | +61.22% |
| Average volume | 275.85K | 125.35K |
| Shares outstanding | 101.84M | 36.54M |
| Employees | 153 | 162 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PROF has outperformed NYXH by 80.4 percentage points over the past year.
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
About Profound Medical
PROF stock →Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.
Health Care · Medical/Dental Instruments · 162 employees
NYXH vs PROF FAQ
Which is bigger, Nyxoah SA or Profound Medical?
Profound Medical (PROF) is larger, with a market capitalization of $252.49M compared with $137.48M for Nyxoah SA (NYXH).
Which stock has performed better over the past year, NYXH or PROF?
PROF returned +2.52% over the past 12 months, compared with -77.87% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are Nyxoah SA and Profound Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.